Harris, D T <br/><br/>
Prevention of graft-versus-host disease (GVHD) by elimination of recipient-reactive donor T cells with recombinant toxins that target the interleukin 2 (IL-2) receptor.  [electronic resource] 

 -  Bone marrow transplantation  Jan 1999 
 - 137-44 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0268-3369 
<br/><br/><label>Standard No.: </label>10.1038/sj.bmt.1701535  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ADP Ribose Transferases<br/>Animals<br/>Bacterial Toxins--pharmacology<br/>Bone Marrow Transplantation--immunology<br/>Cell Count<br/>Exotoxins--pharmacology<br/>Female<br/>Graft vs Host Disease--prevention & control<br/>Humans<br/>Isoantibodies--immunology<br/>Mice<br/>Phenotype<br/>Pregnancy<br/>Pseudomonas aeruginosa<br/>Receptors, Interleukin-2--drug effects<br/>Recombinant Proteins--pharmacology<br/>Stem Cells--physiology<br/>T-Lymphocytes--drug effects<br/>Tissue Donors<br/>Virulence Factors<br/>Pseudomonas aeruginosa Exotoxin A